Zepp Health (ZEPP) Stock Price, News & Analysis

Company Overview

Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.

At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup. Employing proprietary AI algorithms, the company delivers a suite of health-management features—from continuous heart-rate monitoring and sleep staging to PAI (Personal Activity Intelligence) scoring—that appeal to both consumer fitness enthusiasts and professional athletes. The Zepp mobile app serves as the primary interface for users to review trends, set goals and participate in community challenges, reinforcing engagement across its global user base.

Originally founded in 2013 as Huami Corporation, Zepp Health completed its initial public offering on the New York Stock Exchange in July 2021 under the ticker ZEPP. In mid-2022, the company officially adopted the Zepp Health name to underscore its commitment to holistic health technologies. Headquartered in Hefei, China, Zepp Health maintains regional offices and distribution channels across North America, Europe and Asia, supporting sales through e-commerce partners and brick-and-mortar retailers.

Under the leadership of founder and Chief Executive Officer Huang Wang—an early pioneer in wearable health tech—the company continues to expand its product portfolio and pursue strategic collaborations with research institutions and technology partners. Zepp Health’s mission centers on making advanced biometric monitoring accessible to a broad audience, driving innovation in the rapidly evolving intersection of consumer electronics and digital health.

Key Stats

• Today's Range: $6.05 to $6.85
• 50-Day Range: $6.14 to $18.09
• 52-Week Range: $2.25 to $61.85
• Volume: 225,408 shs
• Average Volume: 154,958 shs
• Market Capitalization: $90.06 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $56.28
• Consensus Rating: Hold

Zepp Health Stock Analysis - MarketRank™

Zepp Health scored higher than 55% of companies evaluated by MarketBeat, and ranked 484th out of 865 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.2 / 5
• Analyst Rating: Hold

Consensus Rating

Zepp Health has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.

Upside Potential

Zepp Health has a consensus price target of $56.28, representing about 817.4% upside from its current price of $6.14.

Amount of Analyst Coverage

Zepp Health has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Zepp Health is -2.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Zepp Health is -2.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Zepp Health has a P/B Ratio of 0.42. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.44% of the float of Zepp Health has been sold short.

Short Interest Ratio / Days to Cover

Zepp Health has a short interest ratio ("days to cover") of 2.39, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Zepp Health has recently decreased by 8.85%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Zepp Health does not currently pay a dividend.

Dividend Growth

Zepp Health does not have a long track record of dividend growth.

News and Social Media

• Score: 1.3 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Zepp Health this week, compared to 1 article on an average week.

Search Interest

2 people have searched for ZEPP on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.

MarketBeat Follows

1 people have added Zepp Health to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Zepp Health insiders have not sold or bought any company stock.

Percentage Held by Insiders

36.00% of the stock of Zepp Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

52.61% of the stock of Zepp Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 5/19/2025
• Today: 6/05/2026
• Next Earnings (Estimated): 6/08/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MEDICAL INFO SYS
• Sub-Industry: Computer Hardware
• Current Symbol: NYSE:ZEPP
• CIK: 1720446
• Web: www.huami.com
• Phone: 861059403268
• Fax: N/A
• Employees: 1,230
• Year Founded: 2012

Price Target and Rating

• Average Price Target for Zepp Health: $56.28
• High Price Target: $56.28
• Low Price Target: $56.28
• Potential Upside/Downside: +817.4%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): ($2.51)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$40.07 million
• Net Margins: -15.48%
• Pretax Margin: -13.70%
• Return on Equity: -15.00%
• Return on Assets: -6.07%

Debt

• Debt-to-Equity Ratio: 0.28
• Current Ratio: 1.02
• Quick Ratio: 0.77

Sales & Book Value

• Annual Sales: $258.90 million
• Price / Sales: 0.35
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $14.61 per share
• Price / Book: 0.42

Miscellaneous

• Outstanding Shares: 14,680,000
• Free Float: 9,395,000
• Market Cap: $90.06 million
• Optionable: Optionable
• Beta: 1.78